Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Texas Stroke Institute (TSI) is a specialized neuro-interventional surgery and stroke care network within Medical City Healthcare, a division of HCA Healthcare. It serves as a regional leader in the treatment of complex cerebrovascular diseases, including ischemic and hemorrhagic strokes, brain aneurysms, and arteriovenous malformations. TSI utilizes a "hub-and-spoke" model to provide rapid access to advanced endovascular procedures such as mechanical thrombectomy across the North Texas region. In addition to clinical care, the institute is a major center for clinical research, participating in numerous global trials for neuro-interventional devices and pharmacological treatments. The institute's multidisciplinary team includes fellowship-trained neuro-interventionalists, neurologists, and specialized neuro-critical care staff.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medical City Texas Stroke Institute.